Back to video list Back to Home How might a partial agonist antipsychotic help in optimising treatment outcomes for patients with schizophrenia? You may also like Depression Congress highlights Article Predicting antidepressant response – problems and promises Depression Article The Interplay between Cancer and Depression Alzheimer's Disease Article Vulnerability and resilience in Alzheimer’s Disease Mental Health Congress highlights Article Highlights from ECNP 2022 – Day 1 – October 15th